These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 16423988)

  • 21. Improved gene expression in resting macrophages using an oligopeptide derived from Vpr of human immunodeficiency virus type-1.
    Mizoguchi I; Ooe Y; Hoshino S; Shimura M; Kasahara T; Kano S; Ohta T; Takaku F; Nakayama Y; Ishizaka Y
    Biochem Biophys Res Commun; 2005 Dec; 338(3):1499-506. PubMed ID: 16274667
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HIV-1 Vpr function is mediated by interaction with the damage-specific DNA-binding protein DDB1.
    Schröfelbauer B; Hakata Y; Landau NR
    Proc Natl Acad Sci U S A; 2007 Mar; 104(10):4130-5. PubMed ID: 17360488
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiviral effects of mifepristone on human immunodeficiency virus type-1 (HIV-1): targeting Vpr and its cellular partner, the glucocorticoid receptor (GR).
    Schafer EA; Venkatachari NJ; Ayyavoo V
    Antiviral Res; 2006 Dec; 72(3):224-32. PubMed ID: 16889838
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of the activities of reverse transcriptase and integrase of human immunodeficiency virus type-1 by peptides derived from the homologous viral protein R (Vpr).
    Gleenberg IO; Herschhorn A; Hizi A
    J Mol Biol; 2007 Jun; 369(5):1230-43. PubMed ID: 17490682
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HIV-1 Viral protein-r (Vpr) protects against lethal superantigen challenge while maintaining homeostatic T cell levels in vivo.
    Muthumani K; Choo AY; Hwang DS; Dayes NS; Chattergoon M; Mayilvahanan S; Thieu KP; Buckley PT; Emmanuel J; Premkumar A; Weiner DB
    Mol Ther; 2005 Nov; 12(5):910-21. PubMed ID: 16006193
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human immunodeficiency virus type 1 cell cycle control: Vpr is cytostatic and mediates G2 accumulation by a mechanism which differs from DNA damage checkpoint control.
    Bartz SR; Rogel ME; Emerman M
    J Virol; 1996 Apr; 70(4):2324-31. PubMed ID: 8642659
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HIV-1 Tat depresses DNA-PK(CS) expression and DNA repair, and sensitizes cells to ionizing radiation.
    Sun Y; Huang YC; Xu QZ; Wang HP; Bai B; Sui JL; Zhou PK
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(3):842-50. PubMed ID: 16751065
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of HIV-1 Vpr in AIDS pathogenesis: relevance and implications of intravirion, intracellular and free Vpr.
    Tungaturthi PK; Sawaya BE; Singh SP; Tomkowicz B; Ayyavoo V; Khalili K; Collman RG; Amini S; Srinivasan A
    Biomed Pharmacother; 2003 Jan; 57(1):20-4. PubMed ID: 12642033
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vpr from HIV-1 subtypes B and C exhibit significant differences in their ability to transactivate LTR-mediated gene expression and also in their ability to promote apoptotic DNA ladder formation.
    Bano AS; Gupta N; Sood V; Banerjea AC
    AIDS; 2007 Aug; 21(13):1832-4. PubMed ID: 17690591
    [No Abstract]   [Full Text] [Related]  

  • 30. Multiple centrosome formation induced by the expression of Vpr gene of human immunodeficiency virus.
    Minemoto Y; Shimura M; Ishizaka Y; Masamune Y; Yamashita K
    Biochem Biophys Res Commun; 1999 May; 258(2):379-84. PubMed ID: 10329395
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protein methylation is required to maintain optimal HIV-1 infectivity.
    Willemsen NM; Hitchen EM; Bodetti TJ; Apolloni A; Warrilow D; Piller SC; Harrich D
    Retrovirology; 2006 Dec; 3():92. PubMed ID: 17169163
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of cell differentiation by human immunodeficiency virus 1 vpr.
    Levy DN; Fernandes LS; Williams WV; Weiner DB
    Cell; 1993 Feb; 72(4):541-50. PubMed ID: 8440020
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIV-1 Vpr-induced cell death in Schizosaccharomyces pombe is reminiscent of apoptosis.
    Huard S; Chen M; Burdette KE; Fenyvuesvolgyi C; Yu M; Elder RT; Zhao RY
    Cell Res; 2008 Sep; 18(9):961-73. PubMed ID: 19160543
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of SNF2h, a chromatin-remodeling factor, as a novel binding protein of Vpr of human immunodeficiency virus type 1.
    Taneichi D; Iijima K; Doi A; Koyama T; Minemoto Y; Tokunaga K; Shimura M; Kano S; Ishizaka Y
    J Neuroimmune Pharmacol; 2011 Jun; 6(2):177-87. PubMed ID: 21519849
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vpr in plasma of HIV type 1-positive patients is correlated with the HIV type 1 RNA titers.
    Hoshino S; Sun B; Konishi M; Shimura M; Segawa T; Hagiwara Y; Koyanagi Y; Iwamoto A; Mimaya J; Terunuma H; Kano S; Ishizaka Y
    AIDS Res Hum Retroviruses; 2007 Mar; 23(3):391-7. PubMed ID: 17411372
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Double-labelled HIV-1 particles for study of virus-cell interaction.
    Lampe M; Briggs JA; Endress T; Glass B; Riegelsberger S; Kräusslich HG; Lamb DC; Bräuchle C; Müller B
    Virology; 2007 Mar; 360(1):92-104. PubMed ID: 17097708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complete regression of established subcutaneous B16 murine melanoma tumors after delivery of an HIV-1 Vpr-expressing plasmid by in vivo electroporation.
    McCray AN; Ugen KE; Muthumani K; Kim JJ; Weiner DB; Heller R
    Mol Ther; 2006 Nov; 14(5):647-55. PubMed ID: 16950655
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduction of DNA-damaging effects of anti-HIV drug 3'-azido-3'-dideoxythymidine on human cells by ursolic acid and lignin biopolymer.
    Slamenová D; Horváthová E; Bartková M; Krajcovicová Z; Lábaj J; Kosíková B; Masterová I
    Neoplasma; 2006; 53(6):485-91. PubMed ID: 17167716
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of R77Q, R77A and R80A changes in Vpr on HIV-1 replication and CD4 T cell depletion in human lymphoid tissue ex vivo.
    Rajan D; Wildum S; Rücker E; Schindler M; Kirchhoff F
    AIDS; 2006 Apr; 20(6):831-6. PubMed ID: 16549966
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The presence of human immunodeficiency virus type 1 Vpr correlates with a decrease in the frequency of mutations in a plasmid shuttle vector.
    Jowett JB; Xie YM; Chen IS
    J Virol; 1999 Sep; 73(9):7132-7. PubMed ID: 10438799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.